(Press-News.org) BOSTON (Nov. 12, 2014) - Scientists from Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology have used the power of new genomic technology to discover that microbes that commonly infect the eye have special, previously unknown properties. These properties are predicted to allow the bacterium -- Streptococcus pneumoniae -- to specifically stick to the surface of the eye, grow, and cause damage and inflammation.
Researchers are now using this information to develop new ways to treat and prevent this bacterium, which is becoming increasingly resistant to antibiotics. Their findings are in the current issue of Nature Communications.
S. pneumoniae is a leading cause of infection and is responsible for diseases ranging from infection of the lungs, pneumonia, to infection of the brain, to infection of the surface of the eye known as conjunctivitis. Although infection of the eye can usually be safely treated, S. pneumoniae infection is a leading cause of illness and death worldwide.
According to Mass. Eye and Ear researcher Michael S. Gilmore, Sir William Osler Professor of Ophthalmology, Harvard Medical School, an effective vaccine is available that helps prevent many of the most severe types of infection. "I believe it is especially important for children and the elderly to be vaccinated. The vaccine causes the body to react to a slimy coating on the bacterial surface called a "capsule." The capsule allows S. pneumoniae to escape from white blood cells that try to eliminate it, and S. pneumoniae goes on to cause lung and other infections."
However, the strains of S. pneumoniae that cause eye infection have been known to lack this capsule, yet they still cause infection. "Because they lack the capsule, they are not affected by the vaccine either," he continued.
To design a better vaccine, and to understand how these "unencapsulated" strains of S. pneumoniae are still able to cause infection of the ocular surface, the research team, spearheaded by postdoctoral researcher Michael Valentino and including Mass. Eye and Ear scientists Wolfgang Haas and Paulo Bispo, as well as a collaborative team from the Broad Institute of Harvard University and Massachusetts Institute of Technology, the U.S. Centers for Disease Control and Prevention, and elsewhere, examined the genomes of a large collection of S. pneumoniae strains collected from across the United States.
"We found that about 90 percent of the conjunctivitis strains were very closely related and formed a new group of S. pneumoniae with infectious properties that were different from any other known strains," Dr. Gilmore said. "These new properties are believed to allow S. pneumoniae to resist the normal clearance mechanisms of the surface of the eye, including blinking and tears, stick to the eye surface, grow there and cause damage."
Dr. Gilmore believes that including some of the S. pneumoniae proteins that allow the bacterium to do this in a new type of vaccine, might lead to the prevention of nearly 90 percent of the cases of conjunctivitis caused by this microbe and save the use of antibiotics for more severe infections.
INFORMATION:
The paper, entitled "Unencapsulated Streptococcus pneumoniae from conjunctivitis encode variant traits and belong to a distinct phylogenetic cluster," appears in the Nov. 13 issue of issue of the prestigious international science journal, Nature Communications.
Portions of this project were supported by NIH grants EY024285, Molecular Basis for Ocular Surface Tropism in Conjunctivitis and by the Harvard-wide Program on Antibiotic Resistance, AI083214. HHSN272200900018C supported the involvement of A.M.M. Additional support for this project was obtained from the ALSAC organization of St Jude Children's Research Hospital (J.W.R., C.B., R.A.C. and E.I.T.). In addition, portions of this project were supported by Bausch and Lomb Inc. (C.M.S., W.H., T.W.M. and M.S.G.). M.D.V. was supported in part by NIH fellowship through EY007145.
About Massachusetts Eye and Ear
Massachusetts Eye and Ear clinicians and scientists are driven by a mission to find cures for blindness, deafness and diseases of the head and neck. Led by the Howe Laboratory in Ophthalmology, Schepens Eye Research Institute, and the Eaton-Peabody Laboratory in Otology, Mass. Eye and Ear in Boston is the world's largest vision and hearing research center, offering hope and healing to patients everywhere through discovery and innovation.
Mass. Eye and Ear is a Harvard Medical School teaching hospital that trains future medical leaders in ophthalmology and otolaryngology, through residency as well as clinical and research fellowships. Internationally acclaimed since its founding in 1824, Mass. Eye and Ear employs full-time, board-certified physicians who offer high-quality and affordable specialty care that ranges from the routine to the very complex. U.S. News & World Report's "Best Hospitals Survey" has consistently ranked the Mass. Eye and Ear Departments of Ophthalmology and Otolaryngology as among the best in the nation.
Oral human papillomavirus (HPV) infections were more common among men who had female partners with oral and/or genital HPV infection, suggesting that the transmission of HPV occurs via oral-oral and oral-genital routes, according to a McGill University study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
"HPV is the most common sexually transmitted disease in the world, and is a risk factor for several cancers, including cervical, vaginal, vulvar, oropharyngeal [throat/tonsil], anal, and penile cancer," ...
This news release is available in French. Why are psychotropic drugs such as antidepressants, psychostimulants, anxiolytics, and antipsychotics are increasingly prescribed in North America? Drawing a parallel between the dilemmas facing medicine in the nineteenth century and those that currently exist in the field of mental health, the sociologist and historian Johanne Collin, a professor at the Université de Montréal's Faculty of Pharmacy, believes this increase in prescriptions is partly explained by the therapeutic reasoning of physicians.
"There is an ...
ANN ARBOR, Mich. -- A record number of people are surviving heart attacks and stroke but those who do may experience a sharp decline in physical abilities that steadily accelerates over time, according to a new nationally-representative study led by the University of Michigan.
Heart attack and stroke were associated with a rapid decline in survivors' ability to take care of themselves over the next 10 years, many requiring long-term assistance for daily activities like dressing, bathing, grocery shopping and managing finances. Stroke survivors also appeared to be at ...
This news release is available in French. Montreal, November 11, 2014 -- Regardless of whether a business has been in the family for one year or one thousand, the person in charge typically hopes that handing the reins to a close relative will ensure security for future generations. But that's easier said than done, given that 30 per cent of firms make it to the second generation of family ownership, and only 12 per cent make it to the third.
Concordia University management professor Peter Jaskiewicz believes there's hope for business owners who stay current by focusing ...
Researchers at the University of Notre Dame have designed a simple, yet highly accurate traffic prediction model for roadway transportation networks. They have recently published their work in the journal Nature Communications.
"Transportation networks and in particular the highway transportation network are like the body's circulatory system for the nation," says Zoltán Toroczkai, professor of physics at the University of Notre Dame, who co-authored the study with physics graduate student Yihui Ren and national and international collaborators.
The team's model ...
CORAL GABLES, Fla. (November 11, 2014) -- Researchers at the University of Miami (UM) have developed a family-focused, culturally-informed treatment for schizophrenia (CIT-S). The program is one of the first to incorporate elements of the patient's cultural background as part of therapy. The findings are published online ahead of print, in the Journal of Family Psychology.
The novel treatment aimed to reduce patients' symptoms and improve patient and caregiver emotional well-being, explains Amy Weisman de Mamani, Associate Professor of Psychology in the College of Arts ...
As baby boomers reach their sunset years, shifting nationwide demographics with them, the financial burden of Alzheimer's disease on the United States will skyrocket from $307 billion annually to $1.5 trillion, USC researchers announced today.
Health policy researchers at the USC Leonard D. Schaeffer Center for Health Policy and Economics used models that incorporate trends in health, health care costs, education and demographics to explore the future impact of one of humanity's costliest diseases on the nation's population.
Other key findings include:
From 2010 to ...
A University of Colorado Cancer Center study published online this week in the journal Molecular Cancer Therapeutics reports anti-cancer activity in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733, a small molecule inhibitor of MEK1/2. While the drug is conceived as a second-generation inhibitor in patients harboring the BRAF mutation, the study shows drug activity in melanoma models regardless of BRAF mutation status. Treated tumors shrunk up to 100 percent.
"The importance of this molecule is that it's a next-generation ...
A University of Texas at Arlington physics team is using their expertise in the field of optics and photonics to advance new methods in areas such as mapping the neural circuitry of the brain and guiding neurons to potentially repair damage in the body.
Samarendra Mohanty, an assistant professor of physics, leads the Biophysics and Physiology Lab in the UT Arlington College of Science. He is co-author on two papers published this month. In one published by the online journal PLOS ONE Nov. 10, researchers in Mohanty's lab described using a method called "two-photon optogenetic ...
Making a paper airplane in school used to mean trouble. Today it signals a promising discovery in materials science research that could help next-generation technology -like wearable energy storage devices- get off the ground. Researchers at Drexel University and Dalian University of Technology in China have chemically engineered a new, electrically conductive nanomaterial that is flexible enough to fold, but strong enough to support many times its own weight. They believe it can be used to improve electrical energy storage, water filtration and radiofrequency shielding ...
